Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

NCT04865887 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Metastatic Cervical Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Lenvatinib

Sponsor

Georgetown University

Collaborators

[object Object]